Role of miR-574-Fam210a axis in cardiac hypertrophy and remodeling
miR-574-Fam210a 轴在心脏肥大和重塑中的作用
基本信息
- 批准号:10251906
- 负责人:
- 金额:$ 38.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic AgentsAdultApoptosisBiochemicalBiologyCardiacCardiac Function StudyCardiac MyocytesCardiac healthCardiovascular DiseasesCell Culture TechniquesCell ProliferationCoculture TechniquesDevelopmentDiseaseExhibitsFRAP1 geneFailureFamilyFibroblastsFibrosisGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenetic TranslationGoalsGrowthHeartHeart ContractilitiesHeart DiseasesHeart HypertrophyHeart failureHeterogeneous-Nuclear Ribonucleoprotein LHomeostasisHumanHypertrophyImpairmentInjectionsKnock-outKnockout MiceMediatingMessenger RNAMetabolismMicroRNAsMitochondriaMitochondrial ProteinsMolecular TargetMorbidity - disease rateMusNeonatalNuclearNutrientOperative Surgical ProceduresPathologicPathway interactionsPhenotypePhosphorylationPlayProductionProtein BiosynthesisReagentRegulationResearchResourcesRoleSeriesStressSystemTamoxifenTestingTherapeuticTherapeutic InterventionTranslational RegulationTranslationsTreatment FailureUnited StatesUntranslated RNAVentricular RemodelingWild Type Mousebasecardioprotectionconstrictioncoronary fibrosisexercise trainingexosomeheart functionimprovedin vivoinsightintercellular communicationmembermortalitymouse modelnovelnovel therapeuticspolysome profilingpreventpreventive interventionprotein expressionprotein functionsrc-Family Kinasestherapeutic targettranscriptome sequencingvirtual
项目摘要
Project Summary:
Heart Failure (HF) results from cardiomyocyte (CM) hypertrophy and apoptosis, combined with
cardiac fibroblast (CF) proliferation and fibrosis; these are hallmarks of cardiac pathological
remodelling, which is accompanied by changes in the expression of specific miRNAs and
mitochondrial-encoded genes (MEGs). Early stage cardiac hypertrophy (CH) induces compensatory
mitochondrial protein translation. Endpoint HF is accompanied by reduced mitochondrial protein
synthesis and dysfunctional mitochondria. It is generally accepted that restoring mitochondrial protein
expression and function mitigates HF progression, highlighting the importance of clarifying gene
regulation mechanisms in mitochondria to guide development of improved HF therapeutics. Many
studies have examined mechanisms that coordinate mRNA transcription of nuclear-encoded
mitochondrial genes (NEMGs) and MEGs. However, regulatory mechanisms of MEG mRNA
translation and its coordination with NEMG mRNA translation in the heart remain virtually unexplored.
We have identified a miR-574-Fam210a axis that maintains the optimal translation of MEGs and
mitochondrial homeostasis in both CM and CF, as a compensatory cardioprotective pathway at an
early stage of CH. In contrast to most other single strand miRNAs, miR-574 produces 2 functional
strands, miR-574-5p and miR-574-3p. At early stage of CH, miR-574-5p antagonizes Fam210a
expression in CM to prevent excessive MEG expression, enhanced ROS production and impaired
mitochondrial activity, thereby preventing CM hypertrophy and apoptosis. Moreover, hypertrophic
stress activates Src kinase-mediated Tyr359 phosphorylation and cytoplasmic accumulation of hnRNP
L in CM. P-hnRNP L captures miR-574-3p and promotes exosome-mediated release of miR-574-3p
and reduces cardiac fibroblasts (CF) proliferation by targeting CF Fam210a. Our central hypothesis is:
in CM and CF, miR-574-Fam210a axis maintains optimal translation of mitochondrial-encoded genes
and mitochondrial homeostasis, thereby limiting pathological cardiac hypertrophy and ventricular
remodeling. We will test this hypothesis by pursuing 3 aims. Aim 1. Elucidate the mechanism of guide
strand miR-574-5p in preventing pathological cardiac hypertrophy and CM apoptosis. Aim 2. Establish
the role and mechanism of passenger strand miR-574-3p in antagonizing cardiac fibrosis. Aim 3.
Determine the function and mechanism of Fam210a in mitochondrial translational control and
regulation of cardiac function.
项目总结:
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
FAM114A1 influences cardiac pathological remodeling by regulating angiotensin II signaling.
- DOI:10.1172/jci.insight.152783
- 发表时间:2022-07-08
- 期刊:
- 影响因子:8
- 作者:Subbaiah, Kadiam C. Venkata;Wu, Jiangbin;Tang, Wai Hong Wilson;Yao, Peng
- 通讯作者:Yao, Peng
hnRNP L-mediated RNA switches function as a hypoxia-induced translational regulon.
- DOI:10.1016/j.bbrc.2019.06.106
- 发表时间:2019-08
- 期刊:
- 影响因子:3.1
- 作者:K. V. Venkata Subbaiah;Jiangbin Wu;Alka A. Potdar;Peng Yao
- 通讯作者:K. V. Venkata Subbaiah;Jiangbin Wu;Alka A. Potdar;Peng Yao
Ciclopirox Inhibition of eIF5A Hypusination Attenuates Fibroblast Activation and Cardiac Fibrosis.
- DOI:10.3390/jcdd10020052
- 发表时间:2023-01-29
- 期刊:
- 影响因子:2.4
- 作者:
- 通讯作者:
Aminoacyl-tRNA synthetases in cell signaling.
- DOI:10.1016/bs.enz.2020.04.002
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:P. Yao;P. Fox
- 通讯作者:P. Yao;P. Fox
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peng Yao其他文献
Peng Yao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peng Yao', 18)}}的其他基金
uORF-mediated Translational Control of Cardiac Transcription Factor Expression
uORF介导的心脏转录因子表达的翻译控制
- 批准号:
10659430 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Deciphering the role of FAM210A in cardiac physiopathology
解读 FAM210A 在心脏病理生理学中的作用
- 批准号:
10717728 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Role of miR-574 driver and passenger strands in cardiac hypertrophy
miR-574驱动链和过客链在心脏肥大中的作用
- 批准号:
9336417 - 财政年份:2016
- 资助金额:
$ 38.5万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)